Auscann Group Holdings Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Auscann Group Holdings Ltd with three other
pharmaceutical manufacturers in Australasia:
BCAL Diagnostics Ltd
sales of 275,252.00 Australian Dollars [US$199,458.61 ]
(145,776.00 Australian Dollars [US$105,635.12 ]
of which 100%
was HyperImmune Products), and
Genetic Technologies Limited
(120,554.00 Australian Dollars [US$87,358.25 ]
Auscann Group Holdings Ltd reported sales of A$232,675.00 (US$168.61 thousand)
June of 2021.
decrease of 40.1%
versus 2020, when the company's sales were A$388,532.00 .